Al Ittihad Drug Store

Al Ittihad Drug Store (IDS) is a prominent distributor of essential pharmaceuticals in the United Arab Emirates, with a robust track record of over 400M AED in sales over the past 12 months. Their extensive reach encompasses hospitals, pharmacies, and supermarkets, making them a key player in the UAE's healthcare ecosystem.

IDS has strategically aligned with global brands to introduce a wide array of healthcare products to the UAE market, including offerings for diabetes, hypertension, oncology, and general wellness. They provide end-to-end services for product registration, launch, promotion, and distribution, bolstered by dedicated sales, marketing, and distribution teams, as well as comprehensive logistics and customer service support.

One of the core strengths of IDS lies in its local understanding of consumer behavior and sales strategies, further complemented by specialized expertise in therapeutic classes. Additionally, their regulatory team ensures compliance with the stringent regulatory framework in the UAE, facilitating approvals for sales and distribution.

Notably, IDS has established fruitful collaborations with key entities such as SEHA, Ministry of Health & Prevention, Dubai Health Authority, Abu Dhabi Police, and Dubai Police, underscoring their strong presence in institutional tenders in the region.

As part of GlobalOne Healthcare Holding (GHH), a leading investor in health science in the Gulf region, IDS is backed by a network committed to delivering fully-integrated pharmaceutical, manufacturing, distribution, health-tech, and hospital management solutions.

Overall, Al Ittihad Drug Store (IDS) presents a compelling investment opportunity within the healthcare, manufacturing, and pharmaceutical sectors, supported by its extensive market penetration, strong industry partnerships, and affiliation with the reputable GlobalOne Healthcare Holding.